SRPT peer analysis
Sarepta Therapeutics (SRPT) against its competitors: price, today's move, 1-year return and market value side by side.
SRPT and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALNY Alnylam | $158.00 | -4.24% | -65.35% | $22.10B |
| CAPR Capricor | $7.23 | -0.14% | 16.43% | $370.93M |
| DSGN Design Therapeutics | $10.15 | -4.96% | 51.49% | – |
| DYN Dyne Therapeutics | $17.30 | 3.65% | -23.38% | – |
| IONS Ionis Pharmaceuticals | $41.24 | -5.24% | -44.50% | $7.23B |
| NTLA Intellia | $11.66 | -6.50% | -7.61% | $1.75B |
| PEPG PepGen | $2.35 | -0.42% | -49.57% | – |
| PTCT PTC Therapeutics | $60.88 | 1.52% | -10.88% | $5.01B |
| SLDB Solid Biosciences | $6.00 | -3.23% | 11.32% | $664.80M |
| WVE Wave Life Sciences | $3.52 | -1.95% | -61.06% | $708.05M |
| SRPT Sarepta Therapeutics | $18.32 | -1.61% | -23.70% | $1.97B |
- SRPT's peers: ALNY (Alnylam), CAPR (Capricor), DSGN (Design Therapeutics), DYN (Dyne Therapeutics), IONS (Ionis Pharmaceuticals), NTLA (Intellia), PEPG (PepGen), PTCT (PTC Therapeutics).
Updated 2026-11-03 12:36 UTC